Evonik debuts new synbiotics portfolio
The new nutraceutical synbiotic line is called In Vivo Biotics.
Ingredients supplier Evonik (Essen, Germany) has launched a new nutraceutical range called In Vivo Biotics comprising synbiotic formulas that marry probiotics and other beneficial ingredients. The line includes In Vivo Biotics butyrate, which supports butyrate production; In Vivo Biotics resolvin; and In Vivo Biotics gluten tolerance.
“We believe the human microbiome has great potential for maintaining good health. That’s why we are thrilled to offer our customers science-based nutraceutical solutions like In Vivo Biotics,” said Maximillian Yeh, head of solutions at Evonik’s Health Care business, in a press release.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
